Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
28
TRBC.V Quote, Financials, Valuation and Earnings
Last price:
$0.22
Seasonality move
:
22.46%
Day range:
$0.22 - $0.22
52-week range:
$0.17 - $0.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
13.15x
Volume:
56.5K
Avg. volume:
166.3K
1-year change:
-31.25%
Market cap:
$21.4M
Revenue:
--
EPS (TTM):
-$0.04
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $78K | $61.2K | |
| Selling, General & Admin | -- | -- | $924.5K | $959.8K | $1.1M | |
| Other Inc / (Exp) | $57.4K | $17.4K | -$2.2M | $1.6K | $19.3K | |
| Operating Expenses | -- | -- | $978.9K | $2.5M | $2.1M | |
| Operating Income | -- | -- | -$978.9K | -$2.5M | -$2.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -$3.1M | -$2.4M | -$2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$3.1M | -$2.4M | -$2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$3.1M | -$2.4M | -$2M | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.08 | -$0.04 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -- | -- | -$0.08 | -$0.04 | -$0.04 | |
| Weighted Average Basic Share | -- | -- | $39.5M | $56.6M | $54.9M | |
| Weighted Average Diluted Share | -- | -- | $39.5M | $56.6M | $54.9M | |
| EBITDA | -- | -- | -$978.9K | -$2.5M | -$2.1M | |
| EBIT | -- | -- | -$978.9K | -$2.5M | -$2.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$978.9K | -$2.5M | -$2.1M | |
| Operating Income (Adjusted) | -- | -- | -$978.9K | -$2.5M | -$2.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | $25.6K | $17K | -- | |
| Selling, General & Admin | $65.7K | $45.7K | $218.8K | $304.4K | $227.3K | |
| Other Inc / (Exp) | -- | $121.9K | $60.8K | $10.8K | -- | |
| Operating Expenses | $65.7K | $56.5K | $274.8K | $365.7K | $230.8K | |
| Operating Income | -$65.7K | -$56.5K | -$274.8K | -$365.7K | -$230.8K | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$54K | $65.3K | -$170.4K | -$336.4K | -$229.5K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$54K | $65.3K | -$170.4K | -$336.4K | -$229.5K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$54K | $65.3K | -$170.4K | -$336.4K | -$229.5K | |
| Basic EPS (Cont. Ops) | -$0.00 | $0.00 | -$0.00 | -$0.01 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -$0.00 | $0.00 | -$0.00 | -$0.01 | -$0.00 | |
| Weighted Average Basic Share | $14M | $51.9M | $59.8M | $65.5M | $58.1M | |
| Weighted Average Diluted Share | $14M | $51.9M | $59.8M | $65.5M | $58.1M | |
| EBITDA | -$65.7K | -$56.5K | -$274.8K | -$365.7K | -$230.8K | |
| EBIT | -$65.7K | -$56.5K | -$274.8K | -$365.7K | -$230.8K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$65.7K | -$56.5K | -$274.8K | -$365.7K | -$230.8K | |
| Operating Income (Adjusted) | -$65.7K | -$56.5K | -$274.8K | -$365.7K | -$230.8K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | $91.2K | -- | |
| Selling, General & Admin | $135.7K | $164.7K | $706.1K | $1.1M | $1.6M | |
| Other Inc / (Exp) | -- | $209.4K | -$2.3M | -$5.4K | -- | |
| Operating Expenses | $135.7K | $227.2K | $1.4M | $2.8M | $2.1M | |
| Operating Income | -$135.7K | -$227.2K | -$1.4M | -$2.8M | -$2.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$104.9K | -$23.6K | -$1.3M | -$2.7M | -$2.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$104.9K | -- | -$1.3M | -$2.7M | -$2.1M | |
| Minority Interest in Earnings | -- | -$3.1K | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$104.9K | -$26.7K | -$1.3M | -$2.7M | -$2.1M | |
| Basic EPS (Cont. Ops) | -$0.01 | -$0.00 | -$0.03 | -$0.04 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -$0.01 | -$0.00 | -$0.03 | -$0.04 | -$0.04 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$135.7K | -$162.1K | -$1.4M | -$2.8M | -$2.1M | |
| EBIT | -$135.7K | -$162.1K | -$1.4M | -$2.8M | -$2.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$135.7K | -$227.2K | -$1.4M | -$2.8M | -$2.1M | |
| Operating Income (Adjusted) | -$135.7K | -$162.1K | -$1.4M | -$2.8M | -$2.1M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | $32K | $45.3K | $17.8K | -- | |
| Selling, General & Admin | $105.3K | $663.5K | $799.5K | $1.3M | -- | |
| Other Inc / (Exp) | $144.3K | $11.8K | $4.7K | -$15.6K | -- | |
| Operating Expenses | $116.1K | $1.3M | $1.6M | $1.7M | -- | |
| Operating Income | -$116.1K | -$1.3M | -$1.6M | -$1.7M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $15K | -$1.2M | -$1.5M | -$1.7M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | $15K | -$1.2M | -$1.5M | -$1.7M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $15K | -$1.2M | -$1.5M | -$1.7M | -- | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.02 | -$0.02 | -$0.03 | -- | |
| Diluted EPS (Cont. Ops) | -$0.00 | -$0.02 | -$0.02 | -$0.03 | -- | |
| Weighted Average Basic Share | $79.9M | $164.1M | $190M | $171M | -- | |
| Weighted Average Diluted Share | $79.9M | $164.1M | $190M | $171M | -- | |
| EBITDA | -$116.1K | -$1.3M | -$1.6M | -$1.7M | -- | |
| EBIT | -$116.1K | -$1.3M | -$1.6M | -$1.7M | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$116.1K | -$1.3M | -$1.6M | -$1.7M | -- | |
| Operating Income (Adjusted) | -$116.1K | -$1.3M | -$1.6M | -$1.7M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $2.3M | $3M | $1.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | $54.1K | $48.1K | $67.2K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $2.4M | $3M | $1.9M | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $2.9M | $3.7M | $3.1M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $385.7K | $241.2K | $72.8K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $385.7K | $241.2K | $72.8K | |
| Common Stock | -- | -- | $6M | $9.2M | $10.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | $2.5M | $3.5M | $3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $2.5M | $3.5M | $3M | |
| Total Liabilities and Equity | -- | -- | $2.9M | $3.7M | $3.1M | |
| Cash and Short Terms | -- | -- | $2.3M | $3M | $1.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $740.8K | -- | $4.2M | $2.1M | $211.8K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $1.3K | -- | $84.7K | $62.9K | $21K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $745K | -- | $4.3M | $2.2M | $257.2K | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $745K | -- | $4.8M | $3.5M | $1.8M | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $16.9K | -- | $248.7K | $109.8K | $210.1K | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16.9K | -- | $248.7K | $109.8K | $210.1K | |
| Common Stock | $11.4M | -- | $9.2M | $10.4M | $10.4M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $728.1K | -- | $4.6M | $3.4M | $1.6M | |
| Total Liabilities and Equity | $745K | -- | $4.8M | $3.5M | $1.8M | |
| Cash and Short Terms | $740.8K | -- | $4.2M | $2.1M | $211.8K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$3.1M | -$2.4M | -$2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $23.1K | $105.8K | $352.5K | |
| Change in Accounts Receivable | -- | -- | -$12K | -$12K | -$1.4K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$621.3K | -$2.4M | -$1.8M | |
| Capital Expenditures | -- | -- | $248.3K | $99.9K | $632.9K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$248.3K | -$99.9K | -$632.9K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$38.9K | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | $136.7K | $457.3K | -$172.9K | -$74.7K | |
| Cash From Financing | -- | -- | $3.1M | $3.2M | $1.2M | |
| Beginning Cash (CF) | -- | -- | $2.3M | $3M | $1.8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $2.2M | $674.3K | -$1.2M | |
| Ending Cash (CF) | -- | -- | $4.5M | $3.6M | $599.1K | |
| Levered Free Cash Flow | -- | -- | -$869.6K | -$2.5M | -$2.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$54K | $65.3K | -$170.4K | -$336.4K | -$229.5K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $32.6K | $130.3K | $53.1K | |
| Change in Accounts Receivable | -$2.1K | -$460 | -$4.2K | -$800 | $2.5K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$42.9K | $69.7K | -$191.9K | -$160.4K | -$88K | |
| Capital Expenditures | -- | -- | -- | $313.4K | -$6.1K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$313.4K | $6.1K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$171.4K | -$73.2K | -- | |
| Cash From Financing | -- | -- | $3.2M | $1.2M | -- | |
| Beginning Cash (CF) | $740.8K | $2.2M | $4.2M | $2.1M | $211.8K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$42.9K | $69.7K | $3M | $738K | -$81.9K | |
| Ending Cash (CF) | $697.9K | $2.3M | $7.1M | $2.9M | $129.9K | |
| Levered Free Cash Flow | -$42.9K | $318K | -$191.9K | -$473.8K | -$81.9K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$104.9K | -- | -$1.3M | -$2.7M | -$2.1M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $119.9K | $236.9K | $369.1K | |
| Change in Accounts Receivable | -$1.8K | -- | -$7.3K | -$4.1K | $7.1K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$165.1K | -- | -$1.3M | -$2.6M | -$1.6M | |
| Capital Expenditures | -- | -- | $29K | $677.1K | $338K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$29K | -$677K | -$338K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $3.2M | $1.2M | -$1.5K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$165.1K | -- | $1.9M | -$2M | -$1.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$165K | -- | -$1.3M | -$3.2M | -$1.9M | |
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2026-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15K | -$1.2M | -$1.5M | -$1.7M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | $96.8K | $227.9K | $244.6K | -- | |
| Change in Accounts Receivable | $1.7K | -$7.3K | $600 | $9.2K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $36.4K | -$1.3M | -$1.4M | -$1.3M | -- | |
| Capital Expenditures | -- | $29K | $606.2K | $311.2K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$29K | -$606.2K | -$311.2K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$120.4K | -$171.4K | -$73.2K | -- | -- | |
| Cash From Financing | -- | $3.2M | $1.2M | -- | -- | |
| Beginning Cash (CF) | $3.6M | $6.8M | $5.2M | $1.4M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $36.4K | $1.9M | -$818.1K | -$1.6M | -- | |
| Ending Cash (CF) | $3.6M | $8.7M | $4.4M | -$122.2K | -- | |
| Levered Free Cash Flow | $284.7K | -$1.3M | -$2M | -$1.6M | -- | |
Get TRBC.V Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TRBC.V
Sector
P/E ratio
--
19.88x
PEG ratio
--
-0.02x
P/B ratio
13.15x
1.85x
Price / LTM sales
--
1.65x
Growth Metrics
TRBC.V
Sector
Revenue growth
--
2.4%
Earnings growth
21.57%
--
Revenue (5-year growth)
--
3.24%
Earnings forecast
--
$0.03
Profitability
TRBC.V
Sector
Profitability FY 2024
--
--
Return on invested capital
-85.24%
-9.18%
Return on assets
-81.01%
-10.59%
Return on equity
-85.24%
-9.79%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
Feb
10
Estimated Next Earnings Date
May
12
Balance Sheet
TRBC.V
Sector
Total cash
$211.8K
$2.6M
Short term investments
--
$217K
Total assets
$3.1M
$16.7M
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
